TIFFANY MILLER: Open Payments
NPI 1174386056 · CLAYTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $788
Food & beverage: $773Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $168 |
| Amgen Inc. | 1 | $150 |
| UCB, Inc. | 4 | $95 |
| Lilly USA, LLC | 5 | $94 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: AIRSUPRA, OTEZLA, Bimzelx, MOUNJARO, VRAYLAR, QULIPTA, RINVOQ, UBRELVY.
Industry payments across NC — which companies pay providers there.
